Lyn Willard is a seasoned marketing and bioprocess professional with extensive experience in the biotechnology sector. Currently serving as a Senior Marketing Specialist at Repligen Corporation since January 2021, Lyn previously held a significant role as a Downstream Bioprocess Professional at Alexion, AstraZeneca Rare Disease from October 2001 to February 2022. Earlier in the career, Lyn contributed to Protein Sciences Corporation as a Research Antigen Production Manager from July 1997 to October 2001. Lyn's educational background includes studies at Charter Oak State College and Central Connecticut State University.
This person is not in the org chart
This person is not in any offices